Format

Send to

Choose Destination
Hum Genomics. 2013 Sep 23;7:20. doi: 10.1186/1479-7364-7-20.

K-Map: connecting kinases with therapeutics for drug repurposing and development.

Author information

1
Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. aikchoon.tan@ucdenver.edu.

Abstract

Protein kinases play important roles in regulating signal transduction in eukaryotic cells. Due to evolutionary conserved binding sites in the catalytic domain of the kinases, most inhibitors that target these sites promiscuously inhibit multiple kinases. Quantitative analysis can reveal complex and unexpected interactions between protein kinases and kinase inhibitors, providing opportunities for identifying multi-targeted inhibitors of specific diverse kinases for drug repurposing and development. We have developed K-Map-a novel and user-friendly web-based program that systematically connects a set of query kinases to kinase inhibitors based on quantitative profiles of the kinase inhibitor activities. Users can use K-Map to find kinase inhibitors for a set of query kinases (obtained from high-throughput 'omics' experiments) or to reveal new interactions between kinases and kinase inhibitors for rational drug combination studies.

AVAILABILITY AND IMPLEMENTATION:

K-Map has been implemented in python scripting language and the website is freely available at: http://tanlab.ucdenver.edu/kMap.

PMID:
24060470
PMCID:
PMC3868238
DOI:
10.1186/1479-7364-7-20
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center